What is the address of GJ LIFESCIENCES MANAGEMENT?

The registered office of GJ LIFESCIENCES MANAGEMENT is located at René Comhairelaan 80, 1082 Sint-Agatha-Berchem.

Is GJ LIFESCIENCES MANAGEMENT still active?

Yes. According to the CBE (18 September 2026) GJ LIFESCIENCES MANAGEMENT is active, legal situation “Normale toestand”, started on 9 July 2021.

Is GJ LIFESCIENCES MANAGEMENT registered on Peppol?

Yes, GJ LIFESCIENCES MANAGEMENT is registered on the Peppol network with ID 0208:0770962631.

What is the enterprise number of GJ LIFESCIENCES MANAGEMENT?

The enterprise number of GJ LIFESCIENCES MANAGEMENT is BE0770962631.

When was GJ LIFESCIENCES MANAGEMENT founded?

GJ LIFESCIENCES MANAGEMENT was founded on 9 July 2021.

Who are the directors of GJ LIFESCIENCES MANAGEMENT?

According to the 2025 annual accounts, the directors of GJ LIFESCIENCES MANAGEMENT are: Gilles Jourquin.

Is GJ LIFESCIENCES MANAGEMENT a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 July 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did GJ LIFESCIENCES MANAGEMENT make in 2025?

GJ LIFESCIENCES MANAGEMENT posted a profit after taxes of € 58,081 in financial year 2025.

What is the revenue of GJ LIFESCIENCES MANAGEMENT?

As a small company, GJ LIFESCIENCES MANAGEMENT is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 221,114.

GJ LIFESCIENCES MANAGEMENT (Private Limited)

Q: What does GJ LIFESCIENCES MANAGEMENT do?

GJ LIFESCIENCES MANAGEMENT is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 9 July 2021, 1 establishment.

Dossier GJ LIFESCIENCES MANAGEMENT, printed on 18 September 2026 from databakkes.be/en/0770962631/gj-lifesciences-management. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

GJ LIFESCIENCES MANAGEMENT from Sint-Agatha-Berchem, company number BE0770962631, closed financial year 2025 with a result of € 58,081 after tax. For that financial year GJ LIFESCIENCES MANAGEMENT recorded a gross margin of € 221,114 and equity of € 473,619. Compared with financial year 2024, the result moved from € 92,425 to € 58,081. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 15, 2026.

What it is worth Growing

€ 473,619

▲ 14% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 58,081

▼ 37% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 73,488

▼ 62% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 455,069.

People and assets in 2025

Vehicles and equipment

€ 9,574

▲ 5% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 13 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 525,717

▼ 5% vs 2024

€ 40,214 is repaid this year. At this pace the long-term loan is gone in ≈ 13 years.

Owed to suppliers

€ 28,960

▲ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 15,525

▲ 38% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 214,509 Gross margin 2022: € 214,509 First fiscal year in the series	€ 207,747 Gross margin 2023: € 207,747 ▼ 3% vs 2022 (€ 214,509) Unfavourable step	€ 243,535 Gross margin 2024: € 243,535 ▲ 17% vs 2023 (€ 207,747) Favourable step	€ 221,114 Gross margin 2025: € 221,114 ▼ 9% vs 2024 (€ 243,535) Unfavourable step	▼ 9%
Profit after taxes	€ 162,750 Profit after taxes 2022: € 162,750 First fiscal year in the series	€ 141,814 Profit after taxes 2023: € 141,814 ▼ 13% vs 2022 (€ 162,750) Unfavourable step	€ 92,425 Profit after taxes 2024: € 92,425 ▼ 35% vs 2023 (€ 141,814) Unfavourable step	€ 58,081 Profit after taxes 2025: € 58,081 ▼ 37% vs 2024 (€ 92,425) Unfavourable step	▼ 37%
Equity	€ 181,300 Equity 2022: € 181,300 First fiscal year in the series	€ 323,113 Equity 2023: € 323,113 ▲ 78% vs 2022 (€ 181,300) Favourable step	€ 415,538 Equity 2024: € 415,538 ▲ 29% vs 2023 (€ 323,113) Favourable step	€ 473,619 Equity 2025: € 473,619 ▲ 14% vs 2024 (€ 415,538) Favourable step	▲ 14%
Total debts	€ 52,254 Total debts 2022: € 52,254 First fiscal year in the series	€ 601,403 Total debts 2023: € 601,403 ▲ € 549,149 vs 2022 (€ 52,254) Unfavourable step	€ 621,490 Total debts 2024: € 621,490 ▲ 3% vs 2023 (€ 601,403) Unfavourable step	€ 571,129 Total debts 2025: € 571,129 ▼ 8% vs 2024 (€ 621,490) Favourable step	▼ 8%
Cash	€ 194,581 Cash 2022: € 194,581 First fiscal year in the series	€ 77,797 Cash 2023: € 77,797 ▼ 60% vs 2022 (€ 194,581) Unfavourable step	€ 195,505 Cash 2024: € 195,505 ▲ 151% vs 2023 (€ 77,797) Favourable step	€ 73,488 Cash 2025: € 73,488 ▼ 62% vs 2024 (€ 195,505) Unfavourable step	▼ 62%
Land & buildings	-	€ 790,622 Land & buildings 2023: € 790,622 First fiscal year in the series	€ 766,390 Land & buildings 2024: € 766,390 ▼ 3% vs 2023 (€ 790,622) Unchanged	€ 742,158 Land & buildings 2025: € 742,158 ▼ 3% vs 2024 (€ 766,390) Unchanged	▼ 3%
Retained profit	€ 162,750 Retained profit 2022: € 162,750 First fiscal year in the series	€ 304,563 Retained profit 2023: € 304,563 ▲ 87% vs 2022 (€ 162,750) Favourable step	€ 396,988 Retained profit 2024: € 396,988 ▲ 30% vs 2023 (€ 304,563) Favourable step	€ 455,069 Retained profit 2025: € 455,069 ▲ 15% vs 2024 (€ 396,988) Favourable step	▲ 15%
Bank debt	€ 5,625 Bank debt 2022: € 5,625 First fiscal year in the series	€ 581,563 Bank debt 2023: € 581,563 ▲ € 575,938 vs 2022 (€ 5,625) Unfavourable step	€ 554,415 Bank debt 2024: € 554,415 ▼ 5% vs 2023 (€ 581,563) Favourable step	€ 525,717 Bank debt 2025: € 525,717 ▼ 5% vs 2024 (€ 554,415) Favourable step	▼ 5%
Balance sheet total	€ 233,554 Balance sheet total 2022: € 233,554 First fiscal year in the series	€ 924,517 Balance sheet total 2023: € 924,517 ▲ 296% vs 2022 (€ 233,554) Unchanged	€ 1,037,029 Balance sheet total 2024: € 1,037,029 ▲ 12% vs 2023 (€ 924,517) Unchanged	€ 1,044,749 Balance sheet total 2025: € 1,044,749 ▲ 1% vs 2024 (€ 1,037,029) Unchanged	▲ 1%

Key figures of GJ LIFESCIENCES MANAGEMENT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to GJ LIFESCIENCES MANAGEMENT?

What happened at GJ LIFESCIENCES MANAGEMENT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 15, 2026 New annual accounts for financial year 2025: profit of € 58,081 (▼ 37% vs 2024). filed late Source: NBB ↗
Jul 9, 2021 New establishment in Sint-Agatha-Berchem. KBO
2021 Gilles Jourquin became a director. NBB
Jul 9, 2021 Start of the company according to the CBE. KBO

In short

From € 162,750 profit in 2022 to € 58,081 profit in 2025.

Paid € 130,679 in corporate taxes since 2022.

Best year ever: 2022, with € 162,750 profit.

Original PDFs at the National Bank ↗

A new publication or filing at GJ LIFESCIENCES MANAGEMENT? We notify you, reason included.

Follow GJ LIFESCIENCES MANAGEMENT

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Gilles Jourquin

GJ LIFESCIENCES MANAGEMENT

NEWPHARMA GROUP

Behind GJ LIFESCIENCES MANAGEMENT is Gilles Jourquin. Gilles Jourquin is also behind NEWPHARMA GROUP.

See the full network in the app

Directors

According to the 2025 annual accounts

Gilles Jourquin

Director

Also active at: NEWPHARMA GROUP

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

René Comhairelaan 80

1082 Sint-Agatha-Berchem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0770.962.631

VAT number

BE 0770.962.631

Registered office

René Comhairelaan 80, 1082 Sint-Agatha-Berchem

Names & denominations

GJ LIFESCIENCES MANAGEMENT

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 July 2021

Peppol

Active · Active since 27 Jan 2026

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

GJ LIFESCIENCES MANAGEMENT

Financials

What happened to GJ LIFESCIENCES MANAGEMENT?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions